Werewolf Therapeutics, Inc. (HOWL)
0.9744
-0.01
(-1.43%)
USD |
NASDAQ |
Sep 11, 11:36
Werewolf Therapeutics Total Assets (Quarterly) : 24.16M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.16M |
| March 31, 2026 | 58.02M |
| December 31, 2025 | 69.40M |
| September 30, 2025 | 79.63M |
| June 30, 2025 | 92.57M |
| March 31, 2025 | 107.24M |
| December 31, 2024 | 129.50M |
| September 30, 2024 | 140.04M |
| June 30, 2024 | 153.70M |
| March 31, 2024 | 177.60M |
| December 31, 2023 | 174.83M |
| September 30, 2023 | 176.39M |
| Date | Value |
|---|---|
| June 30, 2023 | 185.24M |
| March 31, 2023 | 195.07M |
| December 31, 2022 | 160.24M |
| September 30, 2022 | 172.42M |
| June 30, 2022 | 175.33M |
| March 31, 2022 | 164.63M |
| December 31, 2021 | 179.25M |
| September 30, 2021 | 178.38M |
| June 30, 2021 | 190.42M |
| March 31, 2021 | 89.44M |
| December 31, 2020 | 96.40M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.863M |
| Shareholders Equity (Quarterly) | 16.29M |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 42.32% |